ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      86.435
      -0.55%
      Bitcoin
      58,171.57
      -3.31%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adial Pharmaceuticals Inc (ADIL)

      7. Adial Pharmaceuticals Inc (ADIL) Financials

      Adial Pharmaceuticals Inc

      Adial Pharmaceuticals Inc (ADIL)

      NASDAQ
      1.05
      0.01
      (0.96%)
      Closed July 04 4:00PM
      Delayed by 15 minutes
      1.05
      0.00
      (0.00%)
      After Hours: 5:00PM
      Delayed by 15 minutes

      Adial Pharmaceuticals Inc Financial Summary

      The current ADIL market cap is 4.44M. The company's latest EPS is USD -1.2102 and P/E is -0.87.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -2.92M-825k-1.36M-1.98M-2.04M
      Net Income -2.91M1.09M-1.39M-1.92M-6.48M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -8.25M-10.93M-17.74M-13.32M-7.08M
      Net Income -8.59M-10.89M-19.42M-12.73M-5.12M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 3.9M3.78M2.87M4.74M6.68M
      Total Liabilities 2.46M462k528k653k562k
      Total Equity 1.44M3.32M2.34M4.08M6.12M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 7.68M5.49M7.48M5.73M4.74M
      Total Liabilities 539k1.51M3.97M2.46M653k
      Total Equity 7.14M3.99M3.51M3.28M4.08M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -2.3M-4.19M-5.58M-6.81M-1.63M
      Investing N/A 800k1.15M1.5M N/A
      Financing 610k610k748k4.13M3.82M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -6.34M-7.63M-11.95M-11.19M-6.81M
      Investing N/A -350k-34k N/A 1.5M
      Financing 9.25M5.61M13.64M9.13M4.13M

      Stats and Ratios

      Market Cap 4.44M
      Price to Earnings Ratio -0.87
      Price to Sales Ratio 0
      Price to Cash Ratio 1.57
      Price to Book Ratio 1.09
      Dividend Yield -

      Share Statistics

      Shares Outstanding 4.23M
      Average Volume (1 week) 55.48k
      Average Volume (1 Month) 230.28k
      52 Week Change -80.79%
      52 Week High 14.00
      52 Week Low 0.765
      Spread (Intraday) 0.08 (7.34%)

      Company Info

      Company Name Adial Pharmaceuticals Inc
      Address corporation trust center 1209 orange st
      wilmington, delaware 19801
      Website https://www.adialpharma.com
      Industry pharmaceutical preparations (2834)